DGAP-Adhoc: Villeroy & Boch AG: Villeroy & Boch with strong increase in sales and record result
2022. január 27., csütörtök, 15:35
DGAP-Ad-hoc: Villeroy & Boch AG / Key word(s): Preliminary Results Preliminary figures for the 2021 financial year: Villeroy & Boch with strong increase in sales and record result Mettlach, 27.01.2022 - In the past financial year, Villeroy & Boch increased its group net sales including licence income by 18 % to € 945 million and thus significantly exceeded the forecast (€ 920 million) last adjusted in September 2021. There are double-digit growth rates in both divisions, which is especially remarkable. The September forecast (€ 85 million) was also clearly exceeded in the group operating result (EBIT) with a record amount of around € 92 million. This is by far the highest group operating result since the IPO in 1990. This extraordinarily positive business development is not only evident compared to 2020, but also in a similar form in comparison to the 2019 financial year, which was unaffected by the pandemic, and thus underlines the substantially improved performance of the Group. Note: Villeroy & Boch will provide information about the final figures for the fourth quarter and the financial year 2021 on 17 February 2022 when the consolidated financial statements are published at the annual press and analysts" conference. Press Relations Contact: Katrin May Head of Corporate Communications Tel: +49 (0) 68 64 81 27 14 E-Mail: may.katrin@villeroy-boch.com Investor Relations Contact: Susanne Reiter Head of Corporate Treasury and Investor Relations Tel: +49 (0) 68 64 81 12 27 E-Mail: reiter.susanne@villeroy-boch.com
|
Language: | English |
Company: | Villeroy & Boch AG |
Saaruferstraße 1-3 | |
66693 Mettlach | |
Germany | |
Phone: | +49 (0)6864 81-0 |
E-mail: | information@villeroy-boch.com |
Internet: | www.villeroy-boch.de |
ISIN: | DE0007657231, DE0007657207 |
WKN: | 765723 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1273779 |
End of Announcement | DGAP News Service |
1273779 27-Jan-2022 CET/CEST
Közzétételek - archívum
-
» Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
[2022.03.08. 15:02]
-
» Evonik und Laxxon Medical sehen Zukunftsmarkt für 3D-Druck von Tabletten
[2022.03.08. 15:02]
-
» "Game Changing" Technology Enables QR Code Integration with 3D Screen Printing
[2022.02.16. 17:31]
-
» Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference
[2022.01.07. 16:40]
-
» EQS-News: Focus Financial Partners Announces the Launch of Beryllus Capital in a Leading-Edge Joint Venture with the Hinduja Group
[2021.03.22. 12:45]
-
» DGAP-Adhoc: TRATON SE: TRATON und Navistar einig über Fortsetzung der Gespräche
[2020.10.16. 18:43]
-
» DGAP-Adhoc: TRATON SE: TRATON and Navistar agreement in principle
[2020.10.16. 18:43]
-
» EQS-News: International Cannabis Company Kaya Holdings, Inc. Enters into Strategic Partnership with U.S.-Israeli Cannabis Innovation Lab
[2020.07.22. 15:00]
-
» EQS-News: International Cannabis Company Kaya Holdings, Inc. and Greek Joint Venture Partner to Launch "Cannamo(TM)" Brand of CBD Pet Products
[2020.07.08. 17:15]